DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 4 Listed Suppliers

4 API Suppliers
4 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 3 Listed Dossiers

3 FDF Dossiers
3 Listed Dossiers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1632006-28-0, Cs-3150, Esaxerenone [inn], Xl-550, N62tgj04a1, 1-(2-hydroxyethyl)-4-methyl-n-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide

Molecular Formula

C₂₂H₂₁F₃N₂O₄S

Molecular Weight

466.5 g/mol

InChI Key

NOSNHVJANRODGR-UHFFFAOYSA-N

FDA UNII

N62TGJ04A1

Esaxerenone is under investigation in clinical trial NCT02722265 (Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension).

1 2D Structure

Esaxerenone

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-(2-hydroxyethyl)-4-methyl-N-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide

2.1.2 InChI

InChI=1S/C22H21F3N2O4S/c1-14-18(21(29)26-15-7-9-16(10-8-15)32(2,30)31)13-27(11-12-28)20(14)17-5-3-4-6-19(17)22(23,24)25/h3-10,13,28H,11-12H2,1-2H3,(H,26,29)

2.1.3 InChI Key

NOSNHVJANRODGR-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=C(N(C=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)C)CCO)C3=CC=CC=C3C(F)(F)F

2.2 Other Identifiers

2.2.1 UNII

N62TGJ04A1

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1-(2-hydroxyethyl)-4-methyl-n-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-1h-pyrrole-3-carboxamide

2. Cs-3150

2.3.2 Depositor-Supplied Synonyms

1. 1632006-28-0

2. Cs-3150

3. Esaxerenone [inn]

4. Xl-550

5. N62tgj04a1

6. 1-(2-hydroxyethyl)-4-methyl-n-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide

7. Unii-n62tgj04a1

8. 1-(2-hydroxyethyl)-4-methyl-n-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-1h-pyrrole-3-carboxamide

9. Chembl2181932

10. 1h-pyrrole-3-carboxamide, 1-(2-hydroxyethyl)-4-methyl-n-(4-(methylsulfonyl)phenyl)-5-(2-(trifluoromethyl)phenyl)-, (5s)-

11. E6r

12. Esaxerenone (jan/inn)

13. Esaxerenone [jan]

14. Esaxerenone [who-dd]

15. Gtpl9894

16. Schembl1381714

17. Dtxsid601336896

18. Glxc-26595

19. Ex-a2595

20. Bdbm50398059

21. Cs-3150 (esaxerenone;xl-550)

22. Akos032946523

23. Cs-8044

24. Db15207

25. Cs-3150; Xl-550

26. Ac-36169

27. Ms-28595

28. Hy-100471

29. A16925

30. D10892

31. Q27284603

32. (+/-)-1-(2-hydroxyethyl)-4-methyl-n-[4-(methylsulfonyl)phenyl]-5-[2-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide

33. 1-(2-hydroxyethyl)-n-(4-methanesulfonylphenyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-1h-pyrrole-3-carboxamide

34. 880780-76-7

2.4 Create Date

2008-11-24

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₁F₃N₂O₄S
Molecular Weight	466.5 g/mol
XLogP3	2.9
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	6
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	96.8
Heavy Atom Count	32
Formal Charge	0
Complexity	747
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

API SUPPLIERS

01

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

02

Excenen PharmaTech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

03

Sunshine Chemical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

04

Ningbo Inno Pharmchem

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

Metrochem API Private Limited

India

Antibody Engineering

Not Confirmed

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

India

Virtual Booth

Digital Content

Esaxerenone

About the Company :

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer